Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1

Bone Marrow Transplantation, Published online: 04 March 2024; doi:10.1038/s41409-024-02255-wReduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1

Source: Bone Marrow Transplantation - March 4, 2024 Category: Hematology Authors: Silvia Park Su-Yeon Bang Daehun Kwag Jong Hyuk Lee Tong Yoon Kim Joonyeop Lee Gi June Min Sung Soo Park Seung-Ah Yahng Young-Woo Jeon Seung-Hwan Shin Jae-Ho Yoon Sung-Eun Lee Byung Sik Cho Ki-Seong Eom Yoo-Jin Kim Seok Lee Chang-Ki Min Seok-Goo Cho Jong W Source Type: research